+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eylea Market by Indication (Age-Related Macular Degeneration, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion), End User (Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics), Distribution Channel, Dosage Frequency - Global Forecast 2025-2030- Product Image
Eylea Market by Indication (Age-Related Macular Degeneration, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion), End User (Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics), Distribution Channel, Dosage Frequency - Global Forecast 2025-2030- Product Image
Sale

Eylea Market by Indication (Age-Related Macular Degeneration, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion), End User (Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics), Distribution Channel, Dosage Frequency - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015393
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Eylea market is evolving rapidly as advanced retinal therapies reshape expectations for ophthalmic treatment, with changing protocols and expanding indications leading to new growth opportunities for industry leaders.

Market Snapshot: Eylea Market Size and Growth

The Eylea market grew from USD 7.25 billion in 2024 to USD 7.77 billion in 2025. Driven by the growing need for effective retinal disorder management, it is expected to continue expanding at a CAGR of 7.12%, ultimately reaching USD 10.96 billion by 2030. Market momentum is attributed to scientific progress in ocular pathophysiology, innovation in vascular endothelial growth factor (VEGF) inhibition, and expansion of product indications beyond macular degeneration to additional sight-threatening retinal conditions.

Scope & Segmentation

This report provides granular insights into the evolving Eylea market by analyzing core segments and regional dynamics influencing market adoption, technology integration, and care delivery models.

  • Indication: Includes age-related macular degeneration, branch retinal vein occlusion, central retinal vein occlusion, diabetic macular edema, and diabetic retinopathy. Understanding indication-specific dynamics is essential for targeting populations with greatest disease burden and unmet clinical needs.
  • End User: Covers ambulatory surgical centers, hospitals, and ophthalmic clinics. Each setting has a specific role, with outpatient centers optimizing workflow, hospitals handling complex multi-disciplinary cases, and clinics providing continuity for chronic care management.
  • Distribution Channel: Encompasses hospital pharmacy, online pharmacy, and retail pharmacy. The growing adoption of online channels meets demand for convenience, while hospital and retail pathways maintain direct patient engagement and timely therapy access.
  • Dosage Frequency: Segments by as-needed, bimonthly, and monthly dosing protocols, allowing for customization of treatment plans based on disease activity and patient adherence needs.
  • Regional Coverage: Analyzes key markets including the Americas (with in-depth coverage of U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with detailed national-level insights), and Asia-Pacific (covering major economies and high-growth emerging regions).
  • Company Developments: Evaluates recent trends and strategies among Regeneron Pharmaceuticals, Bayer, Roche, Novartis, AbbVie, and Bausch Health Companies within the competitive landscape.

Key Takeaways for Senior Decision-Makers

  • Retinal therapy paradigms are shifting as extended-duration formulations, gene therapy advances, and digital health integration support reduced injection frequency, enhanced monitoring, and improved patient outcomes.
  • Strategic partnerships between biopharma, device manufacturers, and healthcare providers facilitate the development of integrated solutions and lifecycle management initiatives, underpinning competitive differentiation.
  • Regional infrastructure and reimbursement policies significantly influence access and therapy adoption, with localized manufacturing and public-private collaborations improving reach in emerging markets.
  • Patient support programs and real-world evidence generation are strengthening clinician-patient relationships, supporting value-based reimbursement, and accelerating clinical adoption in both established and underserved segments.
  • Focused educational initiatives for key care settings increase prescriber awareness of advanced therapies and streamline integration into diverse healthcare delivery models.

Tariff Impact: Navigating US Trade Policy Changes

Upcoming U.S. tariffs on imported pharmaceutical components are prompting manufacturers to re-evaluate sourcing and cost models. To maintain supply continuity and limit procurement disruptions, market players are pursuing local manufacturing alliances and dual-sourcing arrangements. Early engagement with regulatory and payer networks is helping mitigate downstream effects on accessibility and reimbursement.

Methodology & Data Sources

This report leverages rigorous secondary research, drawing from peer-reviewed publications, regulatory approvals, and industry databases. Primary insights were gathered from detailed interviews with retina specialists, healthcare administrators, and executives to ground findings in real market experience. Data validation incorporated cross-triangulation across sources, scenario modeling, and trend extrapolation, ensuring analytical accuracy and relevance.

Eylea Market: Why This Report Matters

  • Provides actionable intelligence for benchmarking therapy adoption, anticipating competitive moves, and planning supply chain resilience.
  • Supports informed investment by highlighting key regional drivers, stakeholder priorities, and innovation areas likely to shape future growth.
  • Enables senior leaders to align strategies with evolving standards of care, payer expectations, and patient-centric delivery models for durable market impact.

Conclusion

The Eylea market is poised for sustained advancement, with stakeholders adapting to therapeutic innovation, evolving policies, and changing care delivery. Aligned strategies will help leaders harness these developments for both patient and organizational success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of Eylea biosimilars challenging market exclusivity and pricing dynamics
5.2. Real-world data revealing variable treatment intervals and impact on patient outcomes
5.3. Adoption of treat-and-extend protocols to reduce injection burden in clinical practice
5.4. Pipeline innovations exploring sustained-release implants to extend Eylea dosing intervals
5.5. Competitive landscape shifts with emerging combination therapies targeting VEGF and PDGF pathways
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Eylea Market, by Indication
8.1. Introduction
8.2. Age-Related Macular Degeneration
8.3. Branch Retinal Vein Occlusion
8.4. Central Retinal Vein Occlusion
8.5. Diabetic Macular Edema
8.6. Diabetic Retinopathy
9. Eylea Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Ophthalmic Clinics
10. Eylea Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Eylea Market, by Dosage Frequency
11.1. Introduction
11.2. As Needed
11.3. Bimonthly
11.4. Monthly
12. Americas Eylea Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Eylea Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Eylea Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Regeneron Pharmaceuticals, Inc.
15.3.2. Bayer Aktiengesellschaft
15.3.3. Roche Holding AG
15.3.4. Novartis AG
15.3.5. AbbVie Inc.
15.3.6. Bausch Health Companies Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. EYLEA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EYLEA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EYLEA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EYLEA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EYLEA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EYLEA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. EYLEA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. EYLEA MARKET: RESEARCHAI
FIGURE 24. EYLEA MARKET: RESEARCHSTATISTICS
FIGURE 25. EYLEA MARKET: RESEARCHCONTACTS
FIGURE 26. EYLEA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EYLEA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EYLEA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EYLEA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EYLEA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EYLEA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EYLEA MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EYLEA MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EYLEA MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EYLEA MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EYLEA MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EYLEA MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EYLEA MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EYLEA MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EYLEA MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EYLEA MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EYLEA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EYLEA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EYLEA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EYLEA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EYLEA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EYLEA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EYLEA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EYLEA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EYLEA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EYLEA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EYLEA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EYLEA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EYLEA MARKET SIZE, BY AS NEEDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EYLEA MARKET SIZE, BY AS NEEDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EYLEA MARKET SIZE, BY BIMONTHLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EYLEA MARKET SIZE, BY BIMONTHLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EYLEA MARKET SIZE, BY MONTHLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EYLEA MARKET SIZE, BY MONTHLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 65. CANADA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. CANADA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. CANADA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. CANADA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. CANADA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. CANADA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. CANADA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 72. CANADA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 73. MEXICO EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. MEXICO EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. MEXICO EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. MEXICO EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. MEXICO EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. MEXICO EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 80. MEXICO EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. BRAZIL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. BRAZIL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. ARGENTINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. ARGENTINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED KINGDOM EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 114. UNITED KINGDOM EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 115. GERMANY EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. GERMANY EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. GERMANY EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. GERMANY EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. GERMANY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. GERMANY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. GERMANY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 122. GERMANY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 123. FRANCE EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. FRANCE EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. FRANCE EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. FRANCE EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. FRANCE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. FRANCE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. FRANCE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 130. FRANCE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. RUSSIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. RUSSIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. RUSSIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 138. RUSSIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 139. ITALY EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. ITALY EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. ITALY EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ITALY EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. ITALY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. ITALY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ITALY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 146. ITALY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 147. SPAIN EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. SPAIN EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. SPAIN EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. SPAIN EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. SPAIN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. SPAIN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. SPAIN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 154. SPAIN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. SAUDI ARABIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 170. SAUDI ARABIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. SOUTH AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 178. SOUTH AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 179. DENMARK EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. DENMARK EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. DENMARK EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. DENMARK EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. DENMARK EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. DENMARK EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. DENMARK EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 186. DENMARK EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. NETHERLANDS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. NETHERLANDS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. NETHERLANDS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 194. NETHERLANDS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 195. QATAR EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. QATAR EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. QATAR EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. QATAR EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. QATAR EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. QATAR EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. QATAR EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 202. QATAR EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 203. FINLAND EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. FINLAND EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. FINLAND EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FINLAND EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. FINLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. FINLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. FINLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 210. FINLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SWEDEN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. SWEDEN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. SWEDEN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 218. SWEDEN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. NIGERIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. NIGERIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. NIGERIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 226. NIGERIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 227. EGYPT EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. EGYPT EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. EGYPT EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EGYPT EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. EGYPT EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. EGYPT EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. EGYPT EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 234. EGYPT EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 235. TURKEY EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. TURKEY EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. TURKEY EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. TURKEY EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. TURKEY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. TURKEY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. TURKEY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 242. TURKEY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ISRAEL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ISRAEL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ISRAEL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 250. ISRAEL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 251. NORWAY EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. NORWAY EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. NORWAY EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. NORWAY EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. NORWAY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. NORWAY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. NORWAY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 258. NORWAY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 259. POLAND EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. POLAND EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. POLAND EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. POLAND EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. POLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. POLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. POLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 266. POLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SWITZERLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SWITZERLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SWITZERLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 274. SWITZERLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 282. ASIA-PACIFIC EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 284. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 285. CHINA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. CHINA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. CHINA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. CHINA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. CHINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. CHINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. CHINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 292. CHINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 293. INDIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. INDIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. INDIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. INDIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. INDIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. INDIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. INDIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 300. INDIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 301. JAPAN EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. JAPAN EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. JAPAN EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. JAPAN EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. JAPAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. JAPAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. JAPAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 308. JAPAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. AUSTRALIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. AUSTRALIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. AUSTRALIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 316. AUSTRALIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. SOUTH KOREA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. SOUTH KOREA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. SOUTH KOREA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 324. SOUTH KOREA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. INDONESIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. INDONESIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. INDONESIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. INDONESIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. INDONESIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 332. INDONESIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 333. THAILAND EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 334. THAILAND EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 335. THAILAND EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. THAILAND EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. THAILAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. THAILAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. THAILAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 340. THAILAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 341. PHILIPPINES EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 342. PHILIPPINES EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 343. PHILIPPINES EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. PHILIPPINES EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. PHILIPPINES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. PHILIPPINES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. PHILIPPINES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 348. PHILIPPINES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 349. MALAYSIA EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 350. MALAYSIA EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 351. MALAYSIA EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. MALAYSIA EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. MALAYSIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. MALAYSIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. MALAYSIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 356. MALAYSIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 357. SINGAPORE EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 358. SINGAPORE EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 359. SINGAPORE EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 360. SINGAPORE EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 361. SINGAPORE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 362. SINGAPORE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 363. SINGAPORE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 364. SINGAPORE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 365. VIETNAM EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 366. VIETNAM EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 367. VIETNAM EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 368. VIETNAM EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 369. VIETNAM EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 370. VIETNAM EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 371. VIETNAM EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 372. VIETNAM EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 373. TAIWAN EYLEA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 374. TAIWAN EYLEA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 375. TAIWAN EYLEA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 376. TAIWAN EYLEA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 377. TAIWAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 378. TAIWAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 379. TAIWAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2024 (USD MILLION)
TABLE 380. TAIWAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025-2030 (USD MILLION)
TABLE 381. EYLEA MARKET SHARE, BY KEY PLAYER, 2024
TABLE 382. EYLEA MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Eylea market report include:
  • Regeneron Pharmaceuticals, Inc.
  • Bayer Aktiengesellschaft
  • Roche Holding AG
  • Novartis AG
  • AbbVie Inc.
  • Bausch Health Companies Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.96 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Eylea HD Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Eylea HD Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Eylea: Market Share, and Growth Analysis by Product Type (Injection, Intravitreal Implant), Application, End User, Technology - Product Image

Eylea: Market Share, and Growth Analysis by Product Type (Injection, Intravitreal Implant), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Eylea Market Report 2025 - Product Image

Eylea Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • Global
From
Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 280 Pages
  • Global
From

About the Eylea Market

Eylea is a cardiovascular drug used to treat a variety of conditions, including age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. It is a recombinant human monoclonal antibody fragment that works by inhibiting the activity of vascular endothelial growth factor (VEGF). This helps to reduce the growth of abnormal blood vessels in the eye, which can lead to vision loss. Eylea is administered as an intravitreal injection, and is typically given every four to eight weeks. The Eylea market is highly competitive, with a number of companies offering similar products. These companies include Regeneron Pharmaceuticals, Novartis, Allergan, and Bayer. Each company has its own unique approach to the market, with different pricing strategies and product offerings. As such, the market is constantly evolving, with new products and strategies being developed to meet the needs of patients. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.